Journal
CLINICAL AND TRANSLATIONAL MEDICINE
Volume 11, Issue 12, Pages -Publisher
JOHN WILEY & SONS LTD
DOI: 10.1002/ctm2.595
Keywords
colorectal cancer; CTCs; EMT; exosomes; metastasis; miR-27b-3p
Categories
Funding
- National Natural Science Foundation of China [81872376]
- National Natural Science Fund Youth Fund of China [81702411, 82103463]
- Zhongnan Hospital of Wuhan University, Technology and Innovation Seed Fund [znpy2016058, CXPY2020025]
- Fundamental Research Funds for the Central Universities [2042021kf0143]
- Zhongnan Hospital of Wuhan University, Excellent Doctor Fund Project [ZNYB2020002]
Ask authors/readers for more resources
This study reveals a novel mechanism by which EMT-CRC cells promote metastasis by increasing blood vessel permeability and facilitating the generation of CTCs through the transfer of exosomal miR-27b-3p. The upregulation of miR-27b-3p in CRC tissues and its positive correlation with malignant progression and CTC count in CRC patients suggest that exosomal miR-27b-3p may become a promising biomarker for CRC metastasis.
Background Metastasis is the main cause of death in colorectal cancer (CRC). Circulating tumour cells (CTCs) are regarded as the precursor cells of metastasis. The CTCs, which underwent epithelial-mesenchymal transition (EMT), are associated with metastasis and responsible for poor prognosis. EMT cancer cells modulate endothelial permeability in the invasive front and facilitate cancer cell intravasation, resulting in CTCs-mediated distant metastasis. Exosomes derived from cancer cells are key mediators of cancer-host intercommunication. However, the mechanism by which EMT-tumour cells-derived exosomes modulate vascular permeability and promote CTCs generation has remained unclear. Methods Exosomes isolation and purification were conducted by ultra-centrifugation. Exosomal miRNA was identified by sequencing followed by quantitative PCR. In vitro co-culture assay experiments were conducted to evaluate the effect of exosomal miR-27b-3p on the permeability of blood vessel endothelium. Dual-luciferase reporter assay, chromatin immunoprecipitation (ChIP) and RNA immunoprecipitation (RIP) were performed to investigate the underlying mechanism by which miR-27b-3p is packaged into exosomes. A mouse model was established to determine the role of exosomal miR-27b-3p in blood vessel permeability modulation in vivo. Results We found that EMT-CRC cells attenuate the blood vessel barrier by transferring miR-27b-3p to human umbilical vein endothelial cells (HUVECs) in exosomes. Mechanically, miR-27b-3p atteuated the expression of vascular endothelial cadherin (VE-Cad) and p120 at the post-transcriptional level by binding to 3 '-untranslated region of VE-Cad and p120 directly. The packaging of miR-27b-3p into exosomes was induced by heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1), which activated by STAT3. Clinically, miR-27b-3p up-regulated in CRC tissues. Plasma exosomal miR-27b-3p was positively correlated with malignant progression and CTC count in CRC patients. Our study reveals a novel mechanism by which EMT-CRC cells promote metastasis, increasing blood vessel permeability and facilitating the generation of CTCs. Conclusion Exosomal miR-27b-3p secreted by EMT-CRC cells increases blood vessel permeability and facilitates the generation of CTCs. Exosomal miR-27b-3p may become a promising biomarker for CRC metastasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available